5-HT2A/5-HT2C receptor agonists (Lundbeck)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT2A/5-HT2C receptor agonists (Lundbeck)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesH. Lundbeck A/S
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A